Get the Stockscreener App
2.74
3.86%
-0.11
Alaunos Therapeutics Inc stock is traded at $2.74, with a volume of 7,272.
It is down -3.86% in the last 24 hours and down -41.58% over the past month.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
See More
Previous Close:
$2.85
Open:
$2.84
24h Volume:
7,272
Relative Volume:
0.19
Market Cap:
$4.49M
Revenue:
-
Net Income/Loss:
$-36.46M
P/E Ratio:
-1.1417
EPS:
-2.4
Net Cash Flow:
$-30.20M
1W Performance:
-2.42%
1M Performance:
-41.58%
6M Performance:
+61.18%
1Y Performance:
-24.73%
1-Day Range:
$2.58
$2.84
1-Week Range:
$2.58
$3.1485
52-Week Range:
$1.3137
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
Name
Alaunos Therapeutics Inc
Sector
Industry
Phone
(346) 355-4099
Address
2617 BISSONNET ST, HOUSTON
Compare TCRT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
2.74 | 4.67M | 0 | -36.46M | -30.20M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Resumed | Wells Fargo | Overweight |
Alaunos Therapeutics Inc Stock (TCRT) Latest News
How to use a screener to detect Alaunos Therapeutics Inc. breakoutsMarket Sentiment Tracker with Smart Alerts - Newser
Using flow based indicators on Alaunos Therapeutics Inc.Free Entry Zone Strategy for Consistent Profit - Newser
Alaunos Therapeutics Inc. Breaks Losing Streak — Is the Trend ReversingReal-Time Trade Insights Spark Market Reactions - metal.it
Using fundamentals and technicals on Alaunos Therapeutics Inc.Free Buy Low Sell High Stock Watch - Newser
Is Alaunos Therapeutics Inc. a candidate for recovery playProven Trading System with Consistent Gains - Newser
Why Alaunos Therapeutics Inc. stock attracts strong analyst attentionSafe Investment Ideas with Growth Upside - Newser
Sector ETF performance correlation with Alaunos Therapeutics Inc.Capital Safe Picks with Consistent Gains - Newser
Intraday pattern recognizer results for Alaunos Therapeutics Inc.Trading Opportunities Forecast by AI Insight - Newser
Does Alaunos Therapeutics Inc. stock pay reliable dividendsVolatility Analysis and Entry Risk Mapping - Newser
Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors - TipRanks
Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment - TipRanks
Published on: 2025-07-30 04:18:21 - Newser
How to build a dashboard for Alaunos Therapeutics Inc. stockDaily Investment Ideas with Market Insight - Newser
How to manage a losing position in Alaunos Therapeutics Inc.Multi-Year Signal Summary and Entry Timing - Newser
Alaunos Therapeutics Inc. Could See a Relief Rally From SupportShort Term Buy Zone Stock Alerts Signal Entry - metal.it
Published on: 2025-07-30 00:51:45 - metal.it
Published on: 2025-07-29 19:04:45 - metal.it
How does Alaunos Therapeutics Inc. compare to its industry peersFree Stock Trend Scanner With Proven Results - jammulinksnews.com
Chart based exit strategy for Alaunos Therapeutics Inc.Minimal Risk Growth Investment Opportunity Analysis - Newser
What are Alaunos Therapeutics Inc. company’s key revenue driversFree Stock Trend Scanner With Proven Results - jammulinksnews.com
Is Alaunos Therapeutics Inc. stock overvalued or undervaluedLow Risk Forecasts For Beginners - jammulinksnews.com
What are the technical indicators suggesting about Alaunos Therapeutics Inc.Get expert advice on portfolio optimization - jammulinksnews.com
How strong is Alaunos Therapeutics Inc. company’s balance sheetCapitalize on emerging market trends - jammulinksnews.com
Why is Alaunos Therapeutics Inc. stock attracting strong analyst attentionCapitalize on emerging industry trends - jammulinksnews.com
What are analysts’ price targets for Alaunos Therapeutics Inc. in the next 12 monthsMassive wealth growth - jammulinksnews.com
What is the risk reward ratio of investing in Alaunos Therapeutics Inc. stockOutstanding stock performance - jammulinksnews.com
Alaunos Therapeutics Holds Annual Stockholders Meeting - MSN
Alaunos Therapeutics stock slides on $2M equity offering - MSN
What analysts say about Alaunos Therapeutics Inc. stockFree AI-Backed Trading Signals - Autocar Professional
Alaunos Therapeutics Announces Departure of Melinda Lackey - The Globe and Mail
What drives Alaunos Therapeutics Inc. stock priceRapidly expanding wealth - Autocar Professional
Is Alaunos Therapeutics Inc. a good long term investmentBreakthrough profit margins - jammulinksnews.com
Alaunos Therapeutics Inc. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com
Alaunos Therapeutics Inc Stock (TCRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):